Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dave Gore's Trades That Make Sense -- Ignore unavailable to you. Want to Upgrade?

To: Prophet who wrote (10320)	7/31/2002 2:57:24 PM
From: Dave Gore	Respond to of 16631

DRUG PLAYS ----- Big news today could spark IVX; also KG, ADVP. Congress defeats senior drug bill. Watch the drugs in the days ahead! One of the few beaten down areas, along with the BTK (which has put in a higher low) that might be a good play for "long" plays. ** BARRONS LIKES IVX / EARNINGS NEWS(really good for a stock down from $35 or 65% from 52 week high)-- Jul 26 2002 6:49 AM In Play Ivax Corp beats by $0.02 on light revs (IVX) 11.00: Posts Q2 net of $0.16 a share, $0.02 better than the Multex consensus, vs yr-ago EPS of $0.33. Revs slid 7% to $280.4 mln (consensus $292.85 mln). Jul 7 2002 9:28 PM In Play Ivax gets bullish article in Barron's** (IVX) 10.70: Barron's discusses the problems that have hit IVX in the past year, but argues that if just a couple of its 35 applications for generics come through, the stock could recover.